Mandate

Vinge advises EQT Infrastructure and Meine Radiologie / Blikk in connection with the acquisition of Aleris’ radiology business

Vinge advises EQT Infrastructure and its portfolio companies Meine Radiologie Holding GmbH and Blikk Holding GmbH in connection with the acquisition of Aleris’ radiology business.

The acquisition includes the full operation of the business area radiology, with 22 units in Sweden and 14 in Norway as well as teleradiology operations in the Baltics, which together carry out more than 1 million radiology exams annually across a broad range of diagnostic imaging modalities.

The acquisition is subject to approval from applicable competition authorities.

Vinge’s team consisted of partner Daniel Rosvall together with Carl Sander, Elsie Nassar, Clara Sohlberg and Ebba Nyberg (M&A), Sam Fakhraie Ardekani (Commercial Agreements), Benjamin Vafaeian (Banking and Financing), Christoffer Nordin (Regulatory and permits), Ulf Pyk (Real Estate), Tove Lövgren Frisk (Compliance), Gustav Lindgren (Employment), Lisa Hörnqvist and Karolina Fuhrman (IT and GDPR), Jolene Reimerson (Separation), Emma Gustavsson (IPR) and Ellinor Gyllenhammar (Project and VDR Assistant).

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025